Target ALS Email Format
Research ServicesNew York, United States11-50 Employees
Target ALS is a non-profit foundation in the research services sector that aims to foster collaboration to accelerate amyotrophic lateral sclerosis drug discovery and development. It is based in New York City at 1740 Broadway, 15th Floor, New York, NY 10019. The organization was founded in 2013 by Dan Doctoroff, a former New York City Deputy Mayor and former CEO of Sidewalk Labs, with support from Bloomberg Philanthropies. It employs 11-50 people and has established initiatives such as the Data Engine launched in 2025 to support data-driven ALS research, along with partnerships and research funding activities. In recent years, Target ALS has announced new research projects and grants, including a 2026 three-year project on C9orf72 disease drivers and a 2026 research grant to AcuraStem Inc. to advance therapeutics targeting SYF2.